Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Sachem Capital (SCCE) Asset Writedowns and Impairment (2016 - 2025)

Historic Asset Writedowns and Impairment for Sachem Capital (SCCE) over the last 5 years, with Q3 2025 value amounting to $185000.0.

  • Sachem Capital's Asset Writedowns and Impairment fell 4218.75% to $185000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $789000.0, marking a year-over-year increase of 6984.18%. This contributed to the annual value of $500000.0 for FY2024, which is 3702.77% down from last year.
  • Sachem Capital's Asset Writedowns and Impairment amounted to $185000.0 in Q3 2025, which was down 4218.75% from $103000.0 recorded in Q4 2024.
  • Over the past 5 years, Sachem Capital's Asset Writedowns and Impairment peaked at $694909.0 during Q4 2022, and registered a low of -$131382.0 during Q3 2023.
  • In the last 4 years, Sachem Capital's Asset Writedowns and Impairment had a median value of $105000.0 in 2022 and averaged $175897.4.
  • Per our database at Business Quant, Sachem Capital's Asset Writedowns and Impairment tumbled by 7395.34% in 2023 and then surged by 34356.46% in 2024.
  • Over the past 4 years, Sachem Capital's Asset Writedowns and Impairment (Quarter) stood at $694909.0 in 2022, then crashed by 73.95% to $181000.0 in 2023, then tumbled by 43.09% to $103000.0 in 2024, then surged by 79.61% to $185000.0 in 2025.
  • Its Asset Writedowns and Impairment was $185000.0 in Q3 2025, compared to $103000.0 in Q4 2024 and $320000.0 in Q3 2024.